Contributor Doug Schoen writes in Forbes (5/27) that “out of pocket costs for medicines” have been hurting older Americans more significantly during the COVID-19 pandemic, but President Trump on Tuesday “introduced the Part D Senior Savings model, a plan that will considerably reduce the price of insulin for people on Medicare.” Under the agreement, “Medicare recipients who pick a plan that offers the new insulin benefit would pay a maximum copay of $35 a month.” Furthermore, “according to the Centers for Medicare & Medicaid Services (CMS), beneficiaries who take insulin and enroll in a participating plan will save $446 a year in out-of-pocket-costs for insulin.” The Washington Post (5/26, Kim, Abutaleb) reports that on Tuesday, the